Corrigendum to "A novel real time PCR strategy to detect SOD3 SNP using LNA probes" [Mutat. Res. 669 (2009) 80-84] (DOI:10.1016/j.mrfmmm.2009.05.007);A novel Real Time PCR strategy to detect SOD3 SNP using LNA probes

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 669, Issue 1-2, 2009, Pages 80-84

  Brugè, Francesca ^a   Littarru, Gian Paolo ^a   Silvestrini, Lucia ^a   Mancuso, Tommaso ^b   Tiano, Luca ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Bio Rad Laboratories Srl   (Italy)

Author keywords

Coronary artery disease; Extracellular superoxide dismutase; Locked nucleic acid; Real Time PCR; SNP detection; TaqMan

Indexed keywords

CYSTEINE; GENOMIC DNA; GLYCINE; LOCKED NUCLEIC ACID; PLASMID DNA; SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE 3; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE; HUMAN; MOLECULAR PROBE; MUTANT; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

AMINO ACID SUBSTITUTION; GENOTYPE; HUMANS; NUCLEIC ACID PROBES; OLIGONUCLEOTIDES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SUPEROXIDE DISMUTASE;

EID: 70349139141     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2009.10.006     Document Type: Erratum

References (23)

1. Marklund S.L., and Hellner L. Superoxide dismutase in extracellular fluids. Clin. Chim. Acta 126 (1982) 41-51
2. Marklund S.L., Bjelle A., and Elmqvist L.G. Superoxide dismutase isoenzymes of the synovial fluid in rheumatoid arthritis and in reactive arthritides. Ann. Rheum. Dis. 45 (1986) 847-851
3. Fattman C.L., Schaefer L.M., and Oury T.D. Extracellular superoxide dismutase in biology and medicine. Free Radic. Biol. Med. 35 (2003) 236-256
4. Adachi T., Yamada H., Futenma A., Kato K., and Hirano K. Heparin-induced release of extracellular-superoxide dismutase form (V) to plasma. J. Biochem. (Tokyo) 117 (1995) 586-590
5. Landmesser U., Merten R., Spiekermann S., Buttner K., Drexler H., and Hornig B. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 101 (2000) 2264-2270
6. Marklund S.L. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem. J. 222 (1984) 649-655
7. Sandstrom J., Nilsson P., Karlsson K., and Marklund S.L. 10-Fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J. Biol. Chem. 269 29 (1994) 19163-19166
8. Adachi T., Yamada H., Yamada Y., Morihara N., Yamazaki N., Murakami T., Futenma A., Kato K., and Hirano K. Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface. Biochem. J. 313 (1996) 235-239
9. Juul K., Tybjaerg-Hansen A., Marklund S., Heegaard N.H., Steffensen R., Sillesen H., Jensen G., and Nordestgaard B.G. Genetically reduced antioxidative protection and increased ischemic heart disease risk: the copenhagen city heart study. Circulation 109 1 (2004) 59-65
10. Nakamura M., Ando Y., Sasada K., Haraoka K., Ueda M., Okabe H., and Motomiya Y. Role of extracellular superoxide dismutase in patients under maintenance hemodialysis. Nephron Clin. Pract. 101 3 (2005) c109-115
11. Yamada H., Yamada Y., Adachi T., Fukatsu A., Sakuma M., Futenma A., and Kakumu S. Protective role of extracellular superoxide dismutase in hemodialysis patients. Nephron 84 3 (2000) 218-223
12. Chistyakov D.A., Savost'anov K.V., Zotova E.V., and Nosikov V.V. Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Med. Genet. 2 (2001) 4-10
13. Tamai M., Furuta H., Kawashima H., Doi A., Hamanishi T., Shimomura H., Sakagashira S., Nishi M., Sasaki H., Sanke T., and Nanjo K. Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes. Diabetes Res. Clin. Pract. 71 2 (2006) 140-145
14. Campo S., Sardo A.M., Campo G.M., D'Ascola A., Avenoso A., Castaldo M., Saitta C., Lania A., Saitta A., and Calabroni A. Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population. Mutat. Res. 578 1-2 (2005) 143-148
15. Lee L.G., Connell C.R., and Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res. 21 16 (1993) 3761-3766
16. Thein S.L., and Wallace R.B. Human Genetic Diseases-A Practical Approach (1986), IRL Press, Oxford
17. Braasch D.A., and Corey D.R. Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem. Biol. 8 1 (2001) 1-7
18. Sambrook J., Fritsch F., and Maniatis T. Molecular Cloning, a Laboratory Manual. second ed. (1989), Cold Spring Harbor Laboratory Press, New York
19. Ugozzoli L.A., Latorra D., Pucket R., Arar K., and Hamby K. Real time genotyping with oligonucleotide probes containing locked nucleic acids. Anal. Biochem. 324 (2004) 143-152
20. Qin Z., Reszka K.J., Fukai T., and Weintraub N.L. Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD. Transl. Res. 151 2 (2008) 68-78
21. Petersen M., and Wengel J. LNA: a versatile tool for therapeutics and genomics. Trends Biotechnol. 21 2 (2003) 74-81
22. You Y., Moreira B.J., Behlke M.A., and Owczarzy R. Design of LNA probes that improve mismatch descrimination. Nucleic Acid Res. 34 8 (2006) e60
23. Nguyen H.K., and Southern E.M. Minimising the secondary structure of DNA targets by incorporation of a modified deoxynucleoside: implications for nucleic acid analysis by hybridisation. Nucleic Acids Res. 28 20 (2000) 3904-3909